Laura Brege, Director at ACADIA PHARMACEUTICALS INC (ACAD), sold 10,000 shares at $24.18 ($242K) on 2014-01-15, disclosed to the SEC on 2014-01-17.
Scheduled sale ($242k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| PCRX | BUY | 2024-08-19 | $13K | — | Filing → |
| ACAD | SELL | 2023-06-14 | $112K | — | Filing → |
| PCRX | SELL | 2023-06-07 | $23K | — | Filing → |